Results
|
21961.
|
|
|
21962.
|
|
|
21963.
|
|
|
21964.
|
|
|
21965.
|
|
|
21966.
|
|
|
21967.
|
|
|
21968.
|
|
|
21969.
|
|
|
21970.
|
|
|
21971.
|
|
|
21972.
|
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. [electronic resource] by
- Eichenauer, Dennis A
- Plütschow, Annette
- Kreissl, Stefanie
- Sökler, Martin
- Hellmuth, Johannes C
- Meissner, Julia
- Mathas, Stephan
- Topp, Max S
- Behringer, Karolin
- Klapper, Wolfram
- Kuhnert, Georg
- Dietlein, Markus
- Kobe, Carsten
- Fuchs, Michael
- Diehl, Volker
- Engert, Andreas
- Borchmann, Peter
Producer: 20171215
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|
|
21973.
|
|
|
21974.
|
|
|
21975.
|
|
|
21976.
|
|
|
21977.
|
|
|
21978.
|
|
|
21979.
|
|
|
21980.
|
|